Instrumentų paieška

biotech

ETF Name

IBB_CFD.ETF

Market

Stocks

Costs

0.06 %

Daily

---

Weekly

---

Yearly

---

Biotech

ISHARES NASDAQ BIOTECH ETF

IBB_CFD.ETF

The coverage offered by hugely popular IBB differs dramatically from most peer funds. It tracks a market-cap-weighted index of NASDAQ-listed biotech companies, while most peer funds use alternative weighting schemes. IBB’s cap-weighting produces a basket that heavily favors large-caps and concentrates exposure in top 10 names. IBB also differs from some peer funds and our segment benchmark in its emphasis on pharmaceuticals. Since the fund can only hold companies traded on the NASDAQ, IBB may miss opportunities in companies traded on the NYSE, which several of the other biotech funds are eligible to hold. This extremely large and liquid product has a good history of tracking its underlying index and does so at a cost towards the lower end of its segment.
Limited-Time Offer:

Until 30 June 2026, enjoy zero commission on your first 10 ETF trades each month. This applies to trades with a total turnover of up to EUR 200,000 monthly. Please review the promotional Terms and Conditions for full details. The lowest commission within the 30 days prior to this offer was 0.1% (minimum 5 PLN / 1 USD / 1 EUR).

Portfolio composition (TOP 10)

09.04.2025
Amgen Inc.
Vertex Pharmaceuticals Incorporated
Gilead Sciences, Inc.
Regeneron Pharmaceuticals, Inc.
Illumina, Inc.
Biogen Inc.
Moderna, Inc.
Seattle Genetics, Inc.
Alexion Pharmaceuticals, Inc.
BioMarin Pharmaceutical Inc.

Biotech

ISHARES NASDAQ BIOTECH ETF

IBB_CFD.ETF

Daily

---

Weekly

---

Yearly

---
The coverage offered by hugely popular IBB differs dramatically from most peer funds. It tracks a market-cap-weighted index of NASDAQ-listed biotech companies, while most peer funds use alternative weighting schemes. IBB’s cap-weighting produces a basket that heavily favors large-caps and concentrates exposure in top 10 names. IBB also differs from some peer funds and our segment benchmark in its emphasis on pharmaceuticals. Since the fund can only hold companies traded on the NASDAQ, IBB may miss opportunities in companies traded on the NYSE, which several of the other biotech funds are eligible to hold. This extremely large and liquid product has a good history of tracking its underlying index and does so at a cost towards the lower end of its segment.

ETF Name

IBB_CFD.ETF

Market

Stocks

Costs

0.06 %

Limited-Time Offer:

Until 30 June 2026, enjoy zero commission on your first 10 ETF trades each month. This applies to trades with a total turnover of up to EUR 200,000 monthly. Please review the promotional Terms and Conditions for full details. The lowest commission within the 30 days prior to this offer was 0.1% (minimum 5 PLN / 1 USD / 1 EUR).

Portfolio composition (TOP 10)

09.04.2025
Amgen Inc.
Vertex Pharmaceuticals Incorporated
Gilead Sciences, Inc.
Regeneron Pharmaceuticals, Inc.
Illumina, Inc.
Biogen Inc.
Moderna, Inc.
Seattle Genetics, Inc.
Alexion Pharmaceuticals, Inc.
BioMarin Pharmaceutical Inc.
Pardavimo kursas Pirkimo kursas
BID 0.0000
ASK 0.0000

Prietaiso specifikacijaISHARES NASDAQ BIOTECH ETF

Name
Minimali užsakymo vertė
Aprašymas
Maksimali užsakymo vertė
Sandorio etapas
Type
Prekybos valandos
Sutarties dydis / 1 lotas
Reikalingas užstatas
1 pipo vertė
Finansinis svertas
Minimalus žingsnis
Ilgas apsikeitimas (kasdienis)
Trumpasis pardavimas NO
Trumpasis apsikeitimas (kasdienis)
Atstumas SL ir TP 0
3 dienų apsikeitimas (data)
Sužinokite daugiau apie Oanda sąskaitą
Scroll to top